小主动脉瓣环患者支架型与快速展开生物瓣的倾向评分分析
这项单中心回顾性研究比较了小主动脉瓣环患者使用快速展开瓣膜(Intuity)与常规支架瓣膜(Magna Ease)的早中期结局。倾向评分加权分析显示,Intuity瓣膜整体及21号尺寸的平均跨瓣压差显著更低,但围术期并发症、5年生存率和再住院率两组相似。
要点
- 小瓣环患者中快速展开瓣膜较常规支架瓣膜提供更优的血流动力学。
- 两组围术期并发症、中期生存和再住院率无显著差异。
- 研究仅纳入19和21号瓣膜,结论需谨慎外推至其他尺寸。
核心结论
- 在小主动脉瓣环患者中,快速展开生物瓣较常规支架瓣膜提供更优的血流动力学表现。
- 但两种瓣膜的围术期结局、中期生存率和再住院率相似。
研究设计与样本
- 回顾性单中心研究,纳入2016年6月至2022年3月期间接受孤立或联合外科主动脉瓣置换术并使用19或21号Magna Ease或Intuity瓣膜的患者。
- 共666例连续患者接受两种瓣膜,Magna Ease 367例(55.1%),Intuity 299例(44.9%);其中Magna Ease 19或21号105例(35.1%),Intuity 19或21号115例(31.3%)。
- 研究人群最终为220例患者,采用倾向评分加权分析校正两组基线差异。
主要发现
- 术后并发症无显著差异。
- Intuity整体平均跨瓣压差显著低于Magna Ease(12 mmHg vs 16 mmHg,P < 0.001)。
- 21号尺寸中,Intuity平均跨瓣压差也显著低于Magna Ease(12 mmHg vs 15 mmHg,P < 0.001)。
- 两种瓣膜中期生存率和再住院率相似(5年再住院率:Magna Ease 17% vs Intuity 20.9%,P = 0.57;5年生存率:Magna Ease 81.9% vs Intuity 88%,P = 0.761)。
临床怎么用
- 对于小主动脉瓣环患者,选择快速展开生物瓣可能有助于获得更低的跨瓣压差。
- 在围术期风险和中期生存方面,两种瓣膜未见显著差异,决策需结合其他因素综合评估。
局限性
- 回顾性单中心设计,样本量有限(最终220例),可能存在选择偏倚。
- 仅纳入19和21号瓣膜,结论不能推广至其他尺寸。
- 随访依赖预定访视和电话访谈,可能存在信息偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Haemodynamic studies have demonstrated the excellent performance of rapid deployment (RD) valves. This retrospective single-centre study aimed to compare early and medium-term outcomes of RD bioprostheses versus conventional stented valves in patients with small aortic annuli. METHODS: We included patients who underwent isolated or combined surgical aortic valve replacement (SAVR) with Magna Ease (ME) and Intuity (Edwards Lifesciences, Irvine, CA) sizes 19 and 21 at our institution between June 2016 and March 2022. Follow-up was conducted through scheduled visits and echocardiograms at the study site, or via telephonic interviews with patients and/or referring cardiologists. A propensity score weighting analysis was performed to account for baseline differences between the 2 cohorts. RESULTS: A total of 666 consecutive patients underwent SAVR with the 2 devices. ME was implanted in 367 patients (55.1%) and Intuity in 299 (44.9%). ME size 19 or 21 was used in 105 patients (35.1%), and Intuity size 19 or 21 in 115 patients (31.3%). Our study population comprised 220 patients. There were no significant differences in postoperative complications. Intuity demonstrated significantly lower gradients overall (mean gradients: 12 mmHg vs 16 mmHg, P < 0.001) and for size 21 (mean gradients: 12 mmHg vs 15 mmHg, P < 0.001). Mid-term survival and rehospitalization rates were similar between the 2 devices (5-year rehospitalization rate: 17% ME vs 20.9% Intuity, P = 0.57; 5-year survival: 81.9% ME vs 88% Intuity, P = 0.761). CONCLUSIONS: In patients with small aortic annuli, RD bioprostheses provide superior haemodynamic outcomes compared to conventional stented valves. However, perioperative outcomes, mid-term survival, and rehospitalization rates are similar between the 2 devices.
引用
- Cibin G, D'Onofrio A, Lombardi V, et al. Propensity score analysis of stented versus rapid deployment aortic bioprostheses in patients with small aortic annulus. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 41071054. doi:10.1093/icvts/ivaf241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。